Thus, our findings underscore the pivotal role of the MEgreen module in the GI tract immune response during COVID-19, linking it to the dysregulation of VEGF expression and the activation of the MAPK pathway, providing insights into potential therapeutic approaches for addressing COVID-19-related complications. The gene discussed is VEGFA; the disease is COVID-19.